Results 131 to 140 of about 53,728 (284)
ABSTRACT Hemophilic pseudotumors, a rare complication of bleeding disorders, are more common in settings with limited access to clotting factor concentrates. Subcutaneous emicizumab, a relatively novel therapy for hemophilia A, was investigated for its ability to stabilize an inoperable pseudotumor in a patient with factor VIII deficiency in an under ...
C. J. Kilach +9 more
wiley +1 more source
Locally applied haemostatic agents in the management of acute epistaxis (nosebleeds)
Peter Kullar +3 more
openalex +2 more sources
Abstract Nasal epithelium is the site of infection for SARS‐CoV2 viruses, with interactions of the viral spike protein with the ACE2 receptor of the host cell. Molecular docking studies have shown that ivermectin shields the spike protein and thereby prevents binding to ACE2.
Stefan Wissel +5 more
wiley +1 more source
Clinical Study of Hospitalized Patient with Recurrent Epistaxis.
Makoto Miyamoto +4 more
openalex +2 more sources
Metastatic Renal Cell Carcinoma to the Paranasal Sinus Presenting as Epistaxis: A Case Report
Tai Iwamura +5 more
openalex +2 more sources
Comparative effectiveness of various noninvasive local treatments in patients with epistaxis: A systematic review and network meta‐analysis [PDF]
Cheng‐Ying Chiang +4 more
openalex +1 more source
ABSTRACT Background Tranexamic acid (TXA) is sometimes used to relieve sore throat discomfort from acute upper‐respiratory tract infection (URTI), but its clinical effect has not been demonstrated in robust randomized controlled trials. Methods The tranexamic acid for URTI study is a randomized double‐blinded clinical trial that was conducted between ...
Naoto Ishimaru +5 more
wiley +1 more source
Homonymous hemianopsia complicating treatment of postoperative epistaxis [PDF]
Patricio S Espinosa +2 more
openalex +1 more source
ABSTRACT Long‐chain fatty acid oxidation disorders (lcFAODs) are genetic disorders of energy metabolism that are associated with a risk of metabolic decompensation, especially during catabolic episodes. With improvement in diagnostics and treatment, more women with lcFAODs now reach child‐bearing age.
Sarah C. Grünert +27 more
wiley +1 more source

